.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

In-person and virtual events just for HCPs

SpecialtySee All >

Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer

Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Emerging Concepts-Advanced Ovarian, Fallopian, Peritoneal, and Cervical Cancers

EP. 1: Introduction: Molecular Testing in Ovarian Cancer

July 2nd 2015

EP. 2: Bevacizumab in Platinum-Resistant Ovarian Cancer

July 2nd 2015

EP. 3: Bevacizumab in Platinum-Sensitive Ovarian Cancer

July 2nd 2015

EP. 4: Frontline Therapy in Advanced Ovarian Cancer

July 2nd 2015

EP. 5: Biomarkers for Bevacizumab in Ovarian Cancer

July 2nd 2015

EP. 6: Utilizing Olaparib in Ovarian Cancer

July 2nd 2015

EP. 7: Managing Platinum-Resistant Ovarian Cancer

July 2nd 2015

EP. 8: Bevacizumab in Advanced Cervical Cancer

July 2nd 2015

EP. 9: Carboplatin Versus Cisplatin in Cervical Cancer

July 2nd 2015

EP. 10: Prevention and Early Detection of Cervical Cancer

July 2nd 2015

EP. 11: Treating Locally Advanced Cervical Cancer

July 2nd 2015

EP. 12: Future of Ovarian and Cervical Cancers

July 2nd 2015